Showing results (1861-1870 of 2,443) with videos related to
Sort By:
Pageof 245
Clinical Genitourinary Cancer|May 27, 2008
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancerRichard T Lee, Kathleen E Beekman, Maha Hussain, et al.Plos Pathogens|February 2, 2016
A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer CellsZachary B Davis, Andrew Cogswell, Hamish Scott, et al.Journal of Hazardous Materials|July 17, 2025
Assessment of sealants for the mitigation of PFAS leaching from contaminated concreteGrant B Douglas, Prashant Srivastava, Rai Kookana, et al.Maternal & Child Nutrition|October 17, 2020
Reframing the early childhood obesity prevention narrative through an equitable nurturing approachHelen Skouteris, Heidi J Bergmeier, Scott D Berns, et al.Journal of the American College of Cardiology|May 1, 1985
Late effects of intracoronary streptokinase on regional wall motion, ventricular aneurysm and left ventricular thrombus in myocardial infarction: results from the Western Washington Randomized TrialJ R Stratton, S M Speck, J H Caldwell, et al.Blood|May 1, 1987
Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B studyH Preisler, R B Davis, J Kirshner, et al.American Heart Journal|October 8, 2005
Association between completeness of percutaneous coronary revascularization and postprocedure outcomesCatherine S McLellan, William A Ghali, Marino Labinaz, et al.Alternative Therapies in Health and Medicine|April 2, 2004
Double-blind placebo-controlled trial of static magnets for the treatment of osteoarthritis of the knee: results of a pilot studyPeter M Wolsko, David M Eisenberg, Lee S Simon, et al.Anticancer Research|October 23, 2009
Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenograftsM Yalcin, D J Bharali, L Lansing, et al.Journal of Cardiovascular Pharmacology|September 16, 2008
Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse modelArzu Ulu, Benjamin B Davis, Hsing-Ju Tsai, et al.Pageof 245